Literature DB >> 17032899

A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.

Lauren D Clarke1, Sylvia K Plevritis, Rob Boer, Kathleen A Cronin, Eric J Feuer.   

Abstract

The CISNET Breast Cancer program is a National Cancer Institute-sponsored collaboration composed of seven research groups that have modeled the impact of screening and adjuvant treatment on trends in breast cancer incidence and mortality over the period 1975-2000 (base case). This collaboration created a unique opportunity to make direct comparison of results from different models of population-based cancer screening produced in response to the same question. Comparing results in all but the most cursory way necessitates comparison of the models themselves. Previous chapters have discussed the models individual in detail. This chapter will aid the reader in understanding key areas of difference between the models. A focused analysis of differences and similarities between the models is presented with special attention paid to areas deemed most likely to contribute substantially to the results of the target analysis.

Entities:  

Mesh:

Year:  2006        PMID: 17032899     DOI: 10.1093/jncimonographs/lgj013

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  21 in total

1.  Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches.

Authors:  Douglas C A Taylor; Vivek Pawar; Denise T Kruzikas; Kristen E Gilmore; Myrlene Sanon; Milton C Weinstein
Journal:  Pharmacoeconomics       Date:  2012-02-01       Impact factor: 4.981

2.  Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Authors:  Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

3.  Modeling the impact of population screening on breast cancer mortality in the United States.

Authors:  Jeanne S Mandelblatt; Kathleen A Cronin; Donald A Berry; Yaojen Chang; Harry J de Koning; Sandra J Lee; Sylvia K Plevritis; Clyde B Schechter; Natasha K Stout; Nicolien T van Ravesteyn; Marvin Zelen; Eric J Feuer
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

Review 4.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Methodological Approaches to Understanding Causes of Health Disparities.

Authors:  Neal Jeffries; Alan M Zaslavsky; Ana V Diez Roux; John W Creswell; Richard C Palmer; Steven E Gregorich; James D Reschovsky; Barry I Graubard; Kelvin Choi; Ruth M Pfeiffer; Xinzhi Zhang; Nancy Breen
Journal:  Am J Public Health       Date:  2019-01       Impact factor: 9.308

6.  Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Authors:  Diego Munoz; Aimee M Near; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Oguzhan Alagoz; Donald A Berry; Elizabeth S Burnside; Yaojen Chang; Gary Chisholm; Harry J de Koning; Mehmet Ali Ergun; Eveline A M Heijnsdijk; Hui Huang; Natasha K Stout; Brian L Sprague; Amy Trentham-Dietz; Jeanne S Mandelblatt; Sylvia K Plevritis
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

7.  Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Authors:  Jeanne S Mandelblatt; Aimee M Near; Diana L Miglioretti; Diego Munoz; Brian L Sprague; Amy Trentham-Dietz; Ronald Gangnon; Allison W Kurian; Harald Weedon-Fekjaer; Kathleen A Cronin; Sylvia K Plevritis
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

8.  Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.

Authors:  Brian L Sprague; Natasha K Stout; Clyde Schechter; Nicolien T van Ravesteyn; Mucahit Cevik; Oguzhan Alagoz; Christoph I Lee; Jeroen J van den Broek; Diana L Miglioretti; Jeanne S Mandelblatt; Harry J de Koning; Karla Kerlikowske; Constance D Lehman; Anna N A Tosteson
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

9.  Socioeconomic disparities in the decline in invasive breast cancer incidence.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Elizabeth S Burnside
Journal:  Breast Cancer Res Treat       Date:  2010-01-20       Impact factor: 4.872

10.  Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.

Authors:  Jeroen J van den Broek; Nicolien T van Ravesteyn; Jeanne S Mandelblatt; Mucahit Cevik; Clyde B Schechter; Sandra J Lee; Hui Huang; Yisheng Li; Diego F Munoz; Sylvia K Plevritis; Harry J de Koning; Natasha K Stout; Marjolein van Ballegooijen
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.